Page last updated: 2024-09-03

sophocarpine and Liver Steatosis

sophocarpine has been researched along with Liver Steatosis in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, SW; Chen, YX; Hu, PF; Ning, BF; Shi, J; Song, CY; Xie, WF; Zeng, X; Zheng, ZW1
Chen, YX; Shi, J; Song, CY; Xie, WF; Zeng, X; Zhang, Y1

Other Studies

2 other study(ies) available for sophocarpine and Liver Steatosis

ArticleYear
Sophocarpine alleviates non-alcoholic steatohepatitis in rats.
    Journal of gastroenterology and hepatology, 2011, Volume: 26, Issue:4

    Topics: Adipokines; Alkaloids; Animals; Anti-Inflammatory Agents; Cytokines; Cytoprotection; Disease Models, Animal; Down-Regulation; Fatty Liver; Inflammation Mediators; Lipids; Liver; Male; Non-alcoholic Fatty Liver Disease; Organ Size; Rats; Rats, Sprague-Dawley; Severity of Illness Index; Time Factors; Transaminases

2011
Sophocarpine alleviates hepatocyte steatosis through activating AMPK signaling pathway.
    Toxicology in vitro : an international journal published in association with BIBRA, 2013, Volume: 27, Issue:3

    Topics: Adipokines; Adiponectin; Alkaloids; AMP-Activated Protein Kinases; Animals; Anti-Inflammatory Agents; Cell Survival; Cells, Cultured; Fatty Liver; Hepatocytes; Male; Non-alcoholic Fatty Liver Disease; Rats; Rats, Sprague-Dawley; Signal Transduction

2013